Expert Ratings For Envista Holdings
Portfolio Pulse from Benzinga Insights
Envista Holdings (NYSE:NVST) has received mixed analyst ratings over the past three months, with 8 analysts offering diverse outlooks. The recent assessments show a shift towards a more cautious stance, with a decrease in bullish ratings and an average 12-month price target of $33.25, down from the previous $43.00. Analysts from UBS, Goldman Sachs, JP Morgan, Morgan Stanley, Piper Sandler, and Stifel have adjusted their ratings and price targets, reflecting changes in market conditions and company performance. Envista Holdings is a dental products company with segments in Specialty Products & Technologies and Equipment & Consumables. Despite a market capitalization below industry benchmarks, the company has shown revenue growth, exceptional net margin, ROE, and ROA, and maintains a healthy debt-to-equity ratio.
January 05, 2024 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Envista Holdings has seen a decrease in bullish sentiment among analysts, with a significant drop in the average 12-month price target to $33.25 from $43.00. The company's financials show strength in net margin, ROE, and ROA, but it has a lower market capitalization compared to industry peers.
The reduction in the average price target suggests a more cautious outlook from analysts, which could lead to short-term negative sentiment among investors. However, the company's strong financial indicators such as net margin, ROE, and ROA may provide some support to the stock price. The relevance is high as the article is directly about Envista Holdings, and the importance is significant due to the potential influence of analyst ratings on investor decisions. The confidence level is high given the clear data provided on analyst ratings and the company's financials.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100